Skip to main content
Type at least 3 characters

2,102 articles

Perspective

Published on 28 Nov 2023

Integrating treatment cost reduction strategies and biomarker research to reduce costs and personalize expensive treatments: an example of a self-funding trial in non-small cell lung cancer

in Drugs Outcomes Research and Policies

  • Alessandra I. G. Buma
  • Berber Piet
  • Rob ter Heine
  • Michel M. van den Heuvel
  • Paul Brinkman
  • Daan van den Broek
  • Sjaak Burgers
  • Francesco Ciompi
  • Simona M. Cristescu
  • Bram van Ginneken
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1274532
  • 2,560 views
  • 6 citations